Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Kyle Hendrix"'
1
Akademický článek
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
Autor: Heather Dahlenburg, David Cameron, Sheng Yang, Angelica Bachman, Kari Pollock, Whitney Cary, Missy Pham, Kyle Hendrix, Jeannine White, Haley Nelson, Peter Deng, Joseph S. Anderson, Kyle Fink, Jan Nolta
Publikováno v: Stem Cells Translational Medicine, Vol 10, Iss 7, Pp 1033-1043 (2021)
Abstract Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab develope
Externí odkaz: https://doaj.org/article/008e3e918fce4a6faf90e4a49f5dc404
Zobrazit plný text záznamu
2
Akademický článek
2203
Autor: Joseph Anderson, Kyle Hendrix, Julie Beegle, Jan A. Nolta, Mehrdad Abedi
Publikováno v: Journal of Clinical and Translational Science, Vol 1, Pp 32-32 (2017)
OBJECTIVES/SPECIFIC AIMS: To date, only 1 documented case of an individual cured of HIV has been reported. He received an allogeneic bone marrow transplant with cells harboring an HIV-resistant genotype. To mimic this result, we have initiated a Phas
Externí odkaz: https://doaj.org/article/f65460617bac43eebdd40f6bfd91d911
Zobrazit plný text záznamu
3
For Which Children with ADHD is TBR Neurofeedback Effective? Comorbidity as a Moderator
Autor: Michelle E. Roley-Roberts, Xueliang Pan, Rachel Bergman, Yubo Tan, Kyle Hendrix, Roger deBeus, Cynthia Kerson, Martijn Arns, Nadja R. Ging Jehli, Shea Connor, Constance Schrader, L. Eugene Arnold
Publikováno v: Applied Psychophysiology and Biofeedback. 48:179-188
Introduction: We examined psychiatric comorbidities moderation of a 2-site double-blind randomized clinical trial of theta/beta-ratio (TBR) neurofeedback (NF) for attention deficit hyperactivity disorder (ADHD). Methods:Seven-to-ten-year-olds with AD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d33ef76e8c6c7cedc1fc6a86abf068
https://doi.org/10.1007/s10484-022-09575-x
Zobrazit plný text záznamu
4
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
Autor: Kyle D. Fink, Heather Dahlenburg, David Cameron, Missy T. Pham, Whitney Cary, Kari Pollock, Haley Nelson, Joseph S. Anderson, Jan A. Nolta, Angelica Bachman, Peter Deng, Kyle Hendrix, Jeannine Logan White, Sheng Yang
Publikováno v: Stem Cells Translational Medicine, Vol 10, Iss 7, Pp 1033-1043 (2021)
Stem Cells Translational Medicine
Stem cells translational medicine, vol 10, iss 7
Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4718c7e5c87caad14d1092219d53005
https://doaj.org/article/008e3e918fce4a6faf90e4a49f5dc404
Zobrazit plný text záznamu
6
Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector
Autor: Haley Maciel, Jan A. Nolta, Joseph S. Anderson, Julie R. Beegle, Kyle Hendrix
Publikováno v: The journal of gene medicineREFERENCES. 22(9)
Background Tay-Sachs and Sandhoff disease are debilitating genetic diseases that affect the central nervous system leading to neurodegeneration through the accumulation of GM2 gangliosides. There are no cures for these diseases and treatments do not
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe5a4424b8b5ace980ae4de78e84731
https://pubmed.ncbi.nlm.nih.gov/32335981
Zobrazit plný text záznamu
8
Mesenchymal stem cell-based therapy for ischemic stroke
Autor: Henrik J. Johansson, Charles S. Bramlett, Michael S. Mulligan, Gary L. Dunbar, Oliver Fiehn, Zelenia Contreras, Kyle Hendrix, Janne Lehtiö, Megan R. Showalter, Gerhard Bauer, Renee L. Bardini, Johnathon D. Anderson, Julien Rossignol, Brian Fury, Jan A. Nolta, Samir El-Andaloussi, Missy T. Pham, Madeline Hoon, Frédéric Chédin, Kyle D. Fink, Billianna Hwang
Publikováno v: Chinese Neurosurgical Journal, vol 2, iss 1
© 2016 The Author(s). Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3776c6310d55101aad50948833b81c
https://escholarship.org/uc/item/4vq889d2
Zobrazit plný text záznamu
9
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
Autor: Alexandria Duffy, Haley Nelson, Joshua Gutierrez, Gerhard Bauer, Heather Dahlenburg, Jan A. Nolta, Karen Pepper, Geralyn Annett, William Gruenloh, Stefanos Kalomoiris, Vicki L. Wheelock, Audrey Torrest, Kyle Hendrix, Johnathon D. Anderson, Peter Deng, Brian Fury, Kyle D. Fink, Catherine Nacey, Whitney Cary, Theresa Tempkin, Kari Pollock, Jeannine McGee
Publikováno v: Molecular Therapy
Molecular therapy : the journal of the American Society of Gene Therapy, vol 24, iss 5
Huntington's disease (HD) is a fatal degenerative autosomal dominant neuropsychiatric disease that causes neuronal death and is characterized by progressive striatal and then widespread brain atrophy. Brain-derived neurotrophic factor (BDNF) is a lea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9eaac23363efa42faa08484d4ef3b79
https://pubmed.ncbi.nlm.nih.gov/26765769
Zobrazit plný text záznamu
10
[Untitled]
Autor: Kyle Hendrix, Mehrdad Abedi, Jan A. Nolta, Joseph Anderson, Julie R. Beegle
Publikováno v: Journal of Clinical and Translational Science. 1:32-32
OBJECTIVES/SPECIFIC AIMS: To date, only 1 documented case of an individual cured of HIV has been reported. He received an allogeneic bone marrow transplant with cells harboring an HIV-resistant genotype. To mimic this result, we have initiated a Phas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fb55189cb437f03d11c54ff6643a09a
https://doi.org/10.1017/cts.2017.120
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje